Neuroprotective Mechanisms as Treatment Strategy in Alzheimers disease
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
239-246
Author(s):
Agneta Nordberg
FKBP Ligands as Novel Therapeutics for Neurological Disorders
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
1
Page:
377-397
Author(s):
C. Christner, T. Herdegen and G. Fischer
Therapeutic Moderate Hypothermia and Fever
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
1533-1536
Author(s):
D. W. Marion
Cytochrome P450 in the Brain ; A Review
Journal:
Current Drug Metabolism
Volume:
2
Page:
245-263
Author(s):
E. Hedlund, J. A. Gustafsson and M. Warner
The Hereditary Disease Array Group (HDAG) - Microarrays, Models and Mechanisms : A Collaboration Update
Journal:
Current Genomics
Volume:
2
Page:
221-229
Author(s):
Tim- Rasmus Kiehl, James M. Olson and Stefan M. Pulst
Azomethine Prodrugs of (R)-alpha-Methylhistamine, a Highly Potent and Selective Histamine H3-Receptor Agonist
Journal:
Current Medicinal Chemistry
Volume:
8
Page:
1329-1340
Author(s):
M. Krause, H. Stark and W. Schunack
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
Journal:
Current Drug Targets
Volume:
2
Page:
241-271
Author(s):
Gene C. Palmer
NMDA Receptors and Learning and Memory Processes
Journal:
Current Drug Targets
Volume:
2
Page:
273-283
Author(s):
C. Castellano, V. Cestari and A. Ciamei
The Application of Phage Display in Allergy Research: Characterization of IgE, Identification of Allergens and Development of Novel Therapeutics
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
225-240
Author(s):
M. R. Edwards, A. M. Collins and R. L. Ward
Immuno-Isolation in Oncology - A Mini-Review
Journal:
Current Pharmaceutical Biotechnology
Volume:
2
Page:
269-277
Author(s):
Pasquale Cirone, Robert M. Saller and Patricia L. Chang